GENEVA, July 18 -- POSEIDA THERAPEUTICS, INC. filed a patent application (US2025/054202) for “COMPOSITIONS TARGETING AU-RICH ELEMENTS OF FGF21 GENE AND GDF15 GENE AND METHODS OF USE THEREOF”. With publication no. WO/2026/102027, here are the other details related to the patent application:
Kind: Later publication of international search report [A3]
IPC: C12N 9/22
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....